sj-docx-1-tct-10.1177_15330338211039676 - Supplemental material for Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study

Supplemental material, sj-docx-1-tct-10.1177_15330338211039676 for Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study by Jie Zhang, Di Wu, Ziran Zhang, Jieran Long, Guangming Tian, Yang Wang, Xiangjuan Ma, Xiaoling Chen, Jindi Han, Weiheng Hu, Ling Dai, Jun Nie and Jian Fang in Technology in Cancer Research & Treatment